1. Home
  2. LEGN vs DBX Comparison

LEGN vs DBX Comparison

Compare LEGN & DBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • DBX
  • Stock Information
  • Founded
  • LEGN 2014
  • DBX 2007
  • Country
  • LEGN United States
  • DBX United States
  • Employees
  • LEGN N/A
  • DBX N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • DBX Computer Software: Prepackaged Software
  • Sector
  • LEGN Health Care
  • DBX Technology
  • Exchange
  • LEGN Nasdaq
  • DBX Nasdaq
  • Market Cap
  • LEGN 7.0B
  • DBX 8.2B
  • IPO Year
  • LEGN 2020
  • DBX 2018
  • Fundamental
  • Price
  • LEGN $27.80
  • DBX $29.61
  • Analyst Decision
  • LEGN Strong Buy
  • DBX Buy
  • Analyst Count
  • LEGN 13
  • DBX 4
  • Target Price
  • LEGN $75.67
  • DBX $31.00
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • DBX 3.6M
  • Earning Date
  • LEGN 05-13-2025
  • DBX 05-08-2025
  • Dividend Yield
  • LEGN N/A
  • DBX N/A
  • EPS Growth
  • LEGN N/A
  • DBX 1.18
  • EPS
  • LEGN N/A
  • DBX 1.48
  • Revenue
  • LEGN $728,303,000.00
  • DBX $2,541,600,000.00
  • Revenue This Year
  • LEGN $65.96
  • DBX N/A
  • Revenue Next Year
  • LEGN $52.55
  • DBX N/A
  • P/E Ratio
  • LEGN N/A
  • DBX $19.95
  • Revenue Growth
  • LEGN 112.46
  • DBX 0.79
  • 52 Week Low
  • LEGN $29.27
  • DBX $20.68
  • 52 Week High
  • LEGN $60.87
  • DBX $33.33
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.31
  • DBX 63.64
  • Support Level
  • LEGN $30.25
  • DBX $29.04
  • Resistance Level
  • LEGN $33.30
  • DBX $30.40
  • Average True Range (ATR)
  • LEGN 1.72
  • DBX 0.69
  • MACD
  • LEGN -0.41
  • DBX 0.09
  • Stochastic Oscillator
  • LEGN 3.14
  • DBX 66.60

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About DBX Dropbox Inc.

Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.

Share on Social Networks: